[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”4.16″ global_colors_info=”{}”][et_pb_row admin_label=”row” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text admin_label=”Text” _builder_version=”4.16″ hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]Doctors recall that the Health Ministry has pointed out that there is no “direct link” between the implants and tumors.
EFE/VALENCIA – The president of the Valencian Society of Plastic Reconstructive and Aesthetic Surgery (SCPRECV), Carlos Tejerina, has assured EFE today that surgeons who have implanted PIP breast prostheses feel that they have been “as deceived as the patients”.
“We use prostheses that are perfectly accepted by the European Union marking,” said Tejerina, who explained that when a product is approved there must be inspectors to ensure that it complies with manufacturing standards: “The failure is undoubtedly there,” she said.
In March 2010, the French authorities detected that the PIP prostheses were manufactured with a different silicone gel than the one declared, which called into question their guarantees, at which time the Spanish Agency of Medicines and Health Products ordered the cessation of the placement of these implants, specifically on the 31st of that same month.
Tejerina, head of the Plastic and Reconstructive Surgery Department of the Hospital Clínico de Valencia, pointed out that “several thousand” patients have been implanted with these prostheses, which have broken in about ten percent of them.
The expert recalled that the Ministry of Health has pointed out that there is no “direct link” between PIP breast prostheses and tumors, the development of breast cancer or “alarming toxicity”, although they do rupture earlier and produce inflammatory alterations.
The vice president of the Spanish Society of Plastic, Reconstructive and Aesthetic Surgery (SECPRE) told EFE that patients are advised to be in direct contact with their surgeon for follow-up and, if there is a suspicion of rupture, to change the prosthesis.
“If the patient has an important alteration due to the prosthesis inside, the surgeon should also change it,” he added.
In his opinion, there should be a “controlled” alarm, and although he pointed out that PIP breast prostheses have had “irregularities” in their manufacture, the health authorities should be heeded.[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
